ChunPeng的个人主页 - 老虎社区

ChunPeng

ChunPeng

暂无个人介绍

IP属地：未知

30关注

5粉丝

0主题

0勋章

2021-11-16

$fuboTV Inc.(FUBO)$守了一年，結果不盡人意。刚全倉賣了，我看不到它明年会有多亮丽的財報。对不起我先止塤⋯⋯

2021-09-24

$Tiger Brokers(TIGR)$A useless stock 😡keep on dropping

2021-01-28

$Obseva Sa(OBSV)$Be patient 😅

2021-09-16

$Tiger Brokers(TIGR)$Everyday goes down

2021-09-16

$Surface Oncology(SURF)$Cut losses and move on. Not worried anymore.

2021-09-28

$Tiger Brokers(TIGR)$Time to cut off and get out of here.

2021-04-02

Nice

抱歉，原内容已删除

2021-02-14

😄

Vivendi plans to distribute 60% of UMG capital to shareholders, list it by year-end<blockquote>维旺迪计划向股东分配60%的UMG capital，年底前上市</blockquote>

2021-02-19

$Surface Oncology(SURF)$😢越走越遠

2021-01-16

Great ariticle, would you like to share it?

@英伟达官方:新年新动力：NVIDIA DRIVE赋能领先电动汽车制造商开启2021

2021-08-13

$VYNE Therapeutics Inc.(VYNE)$What happen to this company?

2021-02-14

Sanofi failed his 3rd stages...

Sanofi's mRNA COVID-19 vaccine candidate not ready this year-CEO<blockquote>赛诺菲的mRNA COVID-19候选疫苗今年尚未准备好——首席执行官</blockquote>

2021-02-06

Not too good

抱歉，原内容已删除

2021-02-03

Not a good news for humankind

抱歉，原内容已删除

2021-10-28

$Microsoft(MSFT)$yes

2021-09-16

$VYNE Therapeutics Inc.(VYNE)$Finally I decid dto give up VYNE.

2021-06-04

$VYNE Therapeutics Inc.(VYNE)$What happen to this company?

2021-05-07

$VYNE Therapeutics Inc.(VYNE)$When will this stock can go up again?

2021-04-15

Great ariticle, would you like to share it?

@克罗伊:$Senseonics(SENS)$Sell or hold?

2021-02-20

Sign of market recover

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3553468686052330","uuid":"3553468686052330","gmtCreate":1590374663493,"gmtModify":1612234242754,"name":"ChunPeng","pinyin":"chunpeng","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":30,"tweetSize":29,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.18","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":871365987,"gmtCreate":1637027369289,"gmtModify":1637027369402,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FUBO\">$fuboTV Inc.(FUBO)$</a>守了一年，結果不盡人意。刚全倉賣了，我看不到它明年会有多亮丽的財報。对不起我先止塤⋯⋯","listText":"<a href=\"https://laohu8.com/S/FUBO\">$fuboTV Inc.(FUBO)$</a>守了一年，結果不盡人意。刚全倉賣了，我看不到它明年会有多亮丽的財報。对不起我先止塤⋯⋯","text":"$fuboTV Inc.(FUBO)$守了一年，結果不盡人意。刚全倉賣了，我看不到它明年会有多亮丽的財報。对不起我先止塤⋯⋯","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/871365987","isVote":1,"tweetType":1,"viewCount":3117,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":854144431,"gmtCreate":1635430190262,"gmtModify":1635430194316,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MSFT\">$Microsoft(MSFT)$</a>yes","listText":"<a href=\"https://laohu8.com/S/MSFT\">$Microsoft(MSFT)$</a>yes","text":"$Microsoft(MSFT)$yes","images":[{"img":"https://static.tigerbbs.com/0eb41ea3c0195e48a0dfe8acf0183127","width":"1242","height":"2448"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/854144431","isVote":1,"tweetType":1,"viewCount":2415,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":862376143,"gmtCreate":1632840423489,"gmtModify":1632840423489,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Time to cut off and get out of here.&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Time to cut off and get out of here.&nbsp;","text":"$Tiger Brokers(TIGR)$Time to cut off and get out of here.","images":[{"img":"https://static.tigerbbs.com/a9601461a837b047afee5c94f57f1933","width":"1242","height":"2448"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/862376143","isVote":1,"tweetType":1,"viewCount":2625,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":861891576,"gmtCreate":1632478233295,"gmtModify":1632719866803,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>A useless stock 😡keep on dropping","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>A useless stock 😡keep on dropping","text":"$Tiger Brokers(TIGR)$A useless stock 😡keep on dropping","images":[{"img":"https://static.tigerbbs.com/fd61c83c4ac0b94fe0b5b41f6e84d4e1","width":"1242","height":"2448"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/861891576","isVote":1,"tweetType":1,"viewCount":2237,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":885276880,"gmtCreate":1631800609540,"gmtModify":1631883589545,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Everyday goes down&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Everyday goes down&nbsp;","text":"$Tiger Brokers(TIGR)$Everyday goes down","images":[{"img":"https://static.tigerbbs.com/13b660a5446aa4be321d11fa689957a8","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/885276880","isVote":1,"tweetType":1,"viewCount":1871,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":885978034,"gmtCreate":1631753960928,"gmtModify":1631883540728,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SURF\">$Surface Oncology(SURF)$</a>Cut losses and move on.&nbsp;Not worried&nbsp;anymore.","listText":"<a href=\"https://laohu8.com/S/SURF\">$Surface Oncology(SURF)$</a>Cut losses and move on.&nbsp;Not worried&nbsp;anymore.","text":"$Surface Oncology(SURF)$Cut losses and move on. Not worried anymore.","images":[{"img":"https://static.tigerbbs.com/e2d7af4f061899ec6557834e13245ff5","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":1,"link":"https://laohu8.com/post/885978034","isVote":1,"tweetType":1,"viewCount":1557,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":885979248,"gmtCreate":1631753804784,"gmtModify":1631885579481,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VYNE\">$VYNE Therapeutics Inc.(VYNE)$</a>Finally I decid dto&nbsp;give up&nbsp;VYNE.&nbsp;","listText":"<a href=\"https://laohu8.com/S/VYNE\">$VYNE Therapeutics Inc.(VYNE)$</a>Finally I decid dto&nbsp;give up&nbsp;VYNE.&nbsp;","text":"$VYNE Therapeutics Inc.(VYNE)$Finally I decid dto give up VYNE.","images":[{"img":"https://static.tigerbbs.com/8fc215c384330dfbc19b446070356be5","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/885979248","isVote":1,"tweetType":1,"viewCount":1192,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":894786263,"gmtCreate":1628857491852,"gmtModify":1631885579625,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VYNE\">$VYNE Therapeutics Inc.(VYNE)$</a>What happen to this company?&nbsp;","listText":"<a href=\"https://laohu8.com/S/VYNE\">$VYNE Therapeutics Inc.(VYNE)$</a>What happen to this company?&nbsp;","text":"$VYNE Therapeutics Inc.(VYNE)$What happen to this company?","images":[{"img":"https://static.tigerbbs.com/a7c206b6845d177c23ae34177ed6d7a5","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/894786263","isVote":1,"tweetType":1,"viewCount":1728,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":116703862,"gmtCreate":1622817549156,"gmtModify":1631885579842,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VYNE\">$VYNE Therapeutics Inc.(VYNE)$</a>What happen to this company?","listText":"<a href=\"https://laohu8.com/S/VYNE\">$VYNE Therapeutics Inc.(VYNE)$</a>What happen to this company?","text":"$VYNE Therapeutics Inc.(VYNE)$What happen to this company?","images":[{"img":"https://static.tigerbbs.com/c5ef85bbab8d041dabda3826393ab5da","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/116703862","isVote":1,"tweetType":1,"viewCount":1169,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":104498878,"gmtCreate":1620401462094,"gmtModify":1631885579931,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VYNE\">$VYNE Therapeutics Inc.(VYNE)$</a>When will this stock can go up again?","listText":"<a href=\"https://laohu8.com/S/VYNE\">$VYNE Therapeutics Inc.(VYNE)$</a>When will this stock can go up again?","text":"$VYNE Therapeutics Inc.(VYNE)$When will this stock can go up again?","images":[{"img":"https://static.tigerbbs.com/9f45ebe32278206b1409cf4db45055ad","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/104498878","isVote":1,"tweetType":1,"viewCount":1249,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":347867166,"gmtCreate":1618486266755,"gmtModify":1631891196872,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/347867166","repostId":"345255525","repostType":1,"repost":{"id":345255525,"gmtCreate":1618321130667,"gmtModify":1631885011003,"author":{"id":"3574041672989370","authorId":"3574041672989370","name":"克罗伊","avatar":"https://static.tigerbbs.com/43f42ce5b407f9b6b1fffd313280897b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574041672989370","idStr":"3574041672989370"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SENS\">$Senseonics(SENS)$</a>Sell or hold?","listText":"<a href=\"https://laohu8.com/S/SENS\">$Senseonics(SENS)$</a>Sell or hold?","text":"$Senseonics(SENS)$Sell or hold?","images":[{"img":"https://static.tigerbbs.com/9cc56fda0d2e9cc3f457a88bab42af3a","width":"1170","height":"2026"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/345255525","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":890,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":340124773,"gmtCreate":1617360530392,"gmtModify":1631891196887,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/340124773","repostId":"1112964874","repostType":4,"isVote":1,"tweetType":1,"viewCount":435,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":360081157,"gmtCreate":1613795587279,"gmtModify":1631891196894,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"Sign of market recover","listText":"Sign of market recover","text":"Sign of market recover","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/360081157","repostId":"2112844585","repostType":2,"isVote":1,"tweetType":1,"viewCount":449,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":384769600,"gmtCreate":1613691100700,"gmtModify":1631888304871,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SURF\">$Surface Oncology(SURF)$</a>😢越走越遠","listText":"<a href=\"https://laohu8.com/S/SURF\">$Surface Oncology(SURF)$</a>😢越走越遠","text":"$Surface Oncology(SURF)$😢越走越遠","images":[{"img":"https://static.tigerbbs.com/f3fe104b2c8b92d95152a7d98cf9aa99","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/384769600","isVote":1,"tweetType":1,"viewCount":1536,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":385497016,"gmtCreate":1613570893235,"gmtModify":1631891196905,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"Very good along with the rise of bitcoin😄","listText":"Very good along with the rise of bitcoin😄","text":"Very good along with the rise of bitcoin😄","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/385497016","repostId":"2112983095","repostType":2,"isVote":1,"tweetType":1,"viewCount":373,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":386797164,"gmtCreate":1613271151458,"gmtModify":1631891196919,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"😄","listText":"😄","text":"😄","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/386797164","repostId":"2111722630","repostType":2,"repost":{"id":"2111722630","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1613214929,"share":"https://www.laohu8.com/m/news/2111722630?lang=zh_CN&edition=full","pubTime":"2021-02-13 19:15","market":"us","language":"en","title":"Vivendi plans to distribute 60% of UMG capital to shareholders, list it by year-end<blockquote>维旺迪计划向股东分配60%的UMG capital，年底前上市</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2111722630","media":"Reuters","summary":"By Dominique Vidalon   PARIS, Feb 13 (Reuters) - Vivendi    said on Saturday it planned to distribut","content":"<p><html><body>By Dominique Vidalon</p><p><blockquote><html><body>多米尼克·维达隆</body></html></blockquote></p><p>   PARIS, Feb 13 (Reuters) - Vivendi    said on Saturday it planned to distribute 60% of Universal Music's capital to investors, subject to shareholder approval, and aimed to list its most-prized asset, home to singers such as Lady Gaga and Taylor Swift, by the end of the year. </p><p><blockquote>路透巴黎2月13日-维旺迪周六表示，计划将环球音乐60%的资本分配给投资者，但须经股东批准，并计划将其最有价值的资产（Lady Gaga和泰勒等歌手的所在地）上市。斯威夫特，到今年年底。</blockquote></p><p>   The plan to list Universal represents part of a process launched by Vivendi's top shareholder French billionaire Vincent Bollore to cash in on the music industry's revival.  </p><p><blockquote>环球公司的上市计划是维旺迪最大股东、法国亿万富翁文森特·博洛雷(Vincent Bollore)为从音乐行业的复兴中获利而发起的进程的一部分。</blockquote></p><p>   \"Vivendi’s leading institutional shareholders have been pressing for a number of years for a split or the distribution of Universal Music Group <a href=\"https://laohu8.com/S/UMG.AU\">$(UMG.AU)$</a> to reduce Vivendi’s conglomerate discount,\" Vivendi said in a statement.</p><p><blockquote>“多年来，维旺迪的主要机构股东一直在敦促拆分或分配环球音乐集团<a href=\"https://laohu8.com/S/UMG.AU\">$(UMG.AU)$</a>减少维旺迪的企业集团折扣，”维旺迪在一份声明中表示。</blockquote></p><p>   The French conglomerate said the distribution would take the form of a special dividend.</p><p><blockquote>这家法国企业集团表示，分配将采取特别股息的形式。</blockquote></p><p>    UMG, a holding company currently being incorporated in the Netherlands, will apply for a listing on Euronext in Amsterdam.</p><p><blockquote>目前在荷兰注册成立的控股公司UMG将申请在阿姆斯特丹泛欧交易所上市。</blockquote></p><p>   The transaction has received a favorable response from the  consortium led by China's tech group Tencent   , which now controls 20% of UMG, having bought the stake in two successive waves that valued UMG at 30 billion euros ($36.35 billion), Vivendi said.  </p><p><blockquote>维旺迪表示，该交易得到了中国科技集团腾讯控股牵头的财团的积极回应，该财团目前控制着UMG 20%的股份，连续两波收购了UMG的股份，对UMG的估值为300亿欧元（363.5亿美元）。</blockquote></p><p>   Vivendi said it would hold an extraordinary shareholders meeting on March 29 to modify the company's by-laws and make the distribution possible.</p><p><blockquote>维旺迪表示，将于3月29日召开临时股东大会，修改公司章程，使分配成为可能。</blockquote></p><p>   In addition, Vivendi will propose to distribute a 0.60 euros per share dividend for its 2020 fiscal year at a shareholders meeting scheduled for June 22.    </p><p><blockquote>此外，维旺迪将在定于6月22日召开的股东大会上提议派发2020财年每股0.60欧元的股息。</blockquote></p><p>($1 = 0.8252 euros)</p><p><blockquote>（1美元=0.8252欧元）</blockquote></p><p> (Reporting by Dominique Vidalon. Editing by Jane Merriman)</p><p><blockquote>（多米尼克·维达隆报道。简·梅里曼编辑）</blockquote></p><p>((dominique.vidalon@thomsonreuters.com; +33149495432; Reuters Messaging: dominique.vidalon.reuters.com@reuters.net))</p><p><blockquote>（（dominique.vidalon@thomsonreuters.com；+33149495432；路透社消息：dominique.vidalon.reuters.com@reuters.net））</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vivendi plans to distribute 60% of UMG capital to shareholders, list it by year-end<blockquote>维旺迪计划向股东分配60%的UMG capital，年底前上市</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVivendi plans to distribute 60% of UMG capital to shareholders, list it by year-end<blockquote>维旺迪计划向股东分配60%的UMG capital，年底前上市</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2021-02-13 19:15</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><html><body>By Dominique Vidalon</p><p><blockquote><html><body>多米尼克·维达隆</body></html></blockquote></p><p>   PARIS, Feb 13 (Reuters) - Vivendi    said on Saturday it planned to distribute 60% of Universal Music's capital to investors, subject to shareholder approval, and aimed to list its most-prized asset, home to singers such as Lady Gaga and Taylor Swift, by the end of the year. </p><p><blockquote>路透巴黎2月13日-维旺迪周六表示，计划将环球音乐60%的资本分配给投资者，但须经股东批准，并计划将其最有价值的资产（Lady Gaga和泰勒等歌手的所在地）上市。斯威夫特，到今年年底。</blockquote></p><p>   The plan to list Universal represents part of a process launched by Vivendi's top shareholder French billionaire Vincent Bollore to cash in on the music industry's revival.  </p><p><blockquote>环球公司的上市计划是维旺迪最大股东、法国亿万富翁文森特·博洛雷(Vincent Bollore)为从音乐行业的复兴中获利而发起的进程的一部分。</blockquote></p><p>   \"Vivendi’s leading institutional shareholders have been pressing for a number of years for a split or the distribution of Universal Music Group <a href=\"https://laohu8.com/S/UMG.AU\">$(UMG.AU)$</a> to reduce Vivendi’s conglomerate discount,\" Vivendi said in a statement.</p><p><blockquote>“多年来，维旺迪的主要机构股东一直在敦促拆分或分配环球音乐集团<a href=\"https://laohu8.com/S/UMG.AU\">$(UMG.AU)$</a>减少维旺迪的企业集团折扣，”维旺迪在一份声明中表示。</blockquote></p><p>   The French conglomerate said the distribution would take the form of a special dividend.</p><p><blockquote>这家法国企业集团表示，分配将采取特别股息的形式。</blockquote></p><p>    UMG, a holding company currently being incorporated in the Netherlands, will apply for a listing on Euronext in Amsterdam.</p><p><blockquote>目前在荷兰注册成立的控股公司UMG将申请在阿姆斯特丹泛欧交易所上市。</blockquote></p><p>   The transaction has received a favorable response from the  consortium led by China's tech group Tencent   , which now controls 20% of UMG, having bought the stake in two successive waves that valued UMG at 30 billion euros ($36.35 billion), Vivendi said.  </p><p><blockquote>维旺迪表示，该交易得到了中国科技集团腾讯控股牵头的财团的积极回应，该财团目前控制着UMG 20%的股份，连续两波收购了UMG的股份，对UMG的估值为300亿欧元（363.5亿美元）。</blockquote></p><p>   Vivendi said it would hold an extraordinary shareholders meeting on March 29 to modify the company's by-laws and make the distribution possible.</p><p><blockquote>维旺迪表示，将于3月29日召开临时股东大会，修改公司章程，使分配成为可能。</blockquote></p><p>   In addition, Vivendi will propose to distribute a 0.60 euros per share dividend for its 2020 fiscal year at a shareholders meeting scheduled for June 22.    </p><p><blockquote>此外，维旺迪将在定于6月22日召开的股东大会上提议派发2020财年每股0.60欧元的股息。</blockquote></p><p>($1 = 0.8252 euros)</p><p><blockquote>（1美元=0.8252欧元）</blockquote></p><p> (Reporting by Dominique Vidalon. Editing by Jane Merriman)</p><p><blockquote>（多米尼克·维达隆报道。简·梅里曼编辑）</blockquote></p><p>((dominique.vidalon@thomsonreuters.com; +33149495432; Reuters Messaging: dominique.vidalon.reuters.com@reuters.net))</p><p><blockquote>（（dominique.vidalon@thomsonreuters.com；+33149495432；路透社消息：dominique.vidalon.reuters.com@reuters.net））</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"00700":"腾讯控股","TCEHY":"腾讯控股ADR","QNETCN":"纳斯达克中美互联网老虎指数","TME":"腾讯音乐"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2111722630","content_text":"By Dominique Vidalon   PARIS, Feb 13 (Reuters) - Vivendi    said on Saturday it planned to distribute 60% of Universal Music's capital to investors, subject to shareholder approval, and aimed to list its most-prized asset, home to singers such as Lady Gaga and Taylor Swift, by the end of the year.    The plan to list Universal represents part of a process launched by Vivendi's top shareholder French billionaire Vincent Bollore to cash in on the music industry's revival.     \"Vivendi’s leading institutional shareholders have been pressing for a number of years for a split or the distribution of Universal Music Group $(UMG.AU)$ to reduce Vivendi’s conglomerate discount,\" Vivendi said in a statement.   The French conglomerate said the distribution would take the form of a special dividend.    UMG, a holding company currently being incorporated in the Netherlands, will apply for a listing on Euronext in Amsterdam.   The transaction has received a favorable response from the  consortium led by China's tech group Tencent   , which now controls 20% of UMG, having bought the stake in two successive waves that valued UMG at 30 billion euros ($36.35 billion), Vivendi said.     Vivendi said it would hold an extraordinary shareholders meeting on March 29 to modify the company's by-laws and make the distribution possible.   In addition, Vivendi will propose to distribute a 0.60 euros per share dividend for its 2020 fiscal year at a shareholders meeting scheduled for June 22.    ($1 = 0.8252 euros) (Reporting by Dominique Vidalon. Editing by Jane Merriman)((dominique.vidalon@thomsonreuters.com; +33149495432; Reuters Messaging: dominique.vidalon.reuters.com@reuters.net))","news_type":1,"symbols_score_info":{"00700":0.9,"TME":0.9,"QNETCN":0.6,"TCEHY":0.6}},"isVote":1,"tweetType":1,"viewCount":392,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":386794771,"gmtCreate":1613271099293,"gmtModify":1631891196956,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"Sanofi failed his 3rd stages...","listText":"Sanofi failed his 3rd stages...","text":"Sanofi failed his 3rd stages...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/386794771","repostId":"2111807728","repostType":2,"repost":{"id":"2111807728","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1613256424,"share":"https://www.laohu8.com/m/news/2111807728?lang=zh_CN&edition=full","pubTime":"2021-02-14 06:47","market":"us","language":"en","title":"Sanofi's mRNA COVID-19 vaccine candidate not ready this year-CEO<blockquote>赛诺菲的mRNA COVID-19候选疫苗今年尚未准备好——首席执行官</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2111807728","media":"Reuters","summary":"PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by Sanofi    and U.S. group Transla","content":"<p><html><body>PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by <a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a>    and U.S. group Translate Bio</p><p><blockquote><html><body>路透巴黎2月13日-由<a href=\"https://laohu8.com/S/GCVRZ\">赛诺菲</a>和美国集团翻译生物</body></html></blockquote></p><p>  \"will not be ready this year,\" the French drugmaker's chief executive told Le Journal du Dimanche newspaper.</p><p><blockquote>“今年不会准备好，”这家法国制药商的首席执行官告诉《星期日报》。</blockquote></p><p>   Clinical trials of this vaccine, which will be based on a technology known as mRNA -- on which lean approved vaccines of Pfizer   /BioNTech    and Moderna    --, are expected to start this quarter.</p><p><blockquote>这种疫苗的临床试验将基于一种名为mRNA的技术——辉瑞/BioNTech和Moderna的精益批准疫苗——预计将于本季度开始。</blockquote></p><p>   In December last year, <a href=\"https://laohu8.com/S/SNYNF\">Sanofi</a> had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data.  </p><p><blockquote>去年12月，<a href=\"https://laohu8.com/S/SNYNF\">赛诺菲</a>该公司表示，在获得积极的临床前数据后，该公司的目标是在2021年下半年“最早可能获得批准”。</blockquote></p><p>   \"This vaccine will not be ready this year, but it could be of use at a later stage all the more if the fight against variants was to continue,\" Paul Hudson was quoted as saying.</p><p><blockquote>报道援引保罗·哈德森的话说：“这种疫苗今年不会准备好，但如果要继续对抗变种，它可能会在稍后阶段发挥更大的作用。”</blockquote></p><p>   The CEO gave no other details. Officials at Sanofi were not available for comment.</p><p><blockquote>首席执行官没有透露其他细节。未能联系到赛诺菲的官员置评。</blockquote></p><p>   The news could mark another blow for Sanofi, already embattled with a delay for another COVID-19 vaccine candidate it hopes to bring to patients and for which the company has teamed up with Britain's GlaxoSmithKline   .</p><p><blockquote>这一消息可能标志着赛诺菲的又一次打击，赛诺菲希望向患者提供的另一种COVID-19候选疫苗的延迟已经陷入困境，该公司已与英国葛兰素史克合作。</blockquote></p><p>   The two groups stunned investors last year by warning their traditional, protein-based COVID-19 jab showed an insufficient immune response in older people, delaying its launch towards the end of 2021.  </p><p><blockquote>去年，这两个组织警告说，他们传统的基于蛋白质的COVID-19疫苗在老年人中显示出免疫反应不足，因此将其推出推迟到2021年底，这让投资者感到震惊。</blockquote></p><p>   To appease critics, Sanofi said last month it had agreed to fill and pack millions of doses of the Pfizer/BioNTech vaccine from July.  </p><p><blockquote>为了安抚批评者，赛诺菲上个月表示，已同意从7月份开始灌装和包装数百万剂辉瑞/BioNTech疫苗。</blockquote></p><p>   Some 108 million people have been reported to be infected by the novel coronavirus globally and more than 2.4 million have died since first cases were identified in China in December 2019, according to a Reuters tally.</p><p><blockquote>据路透社统计，自2019年12月中国发现首例病例以来，全球已有约1.08亿人感染新型冠状病毒病毒，已有超过240万人死亡。</blockquote></p><p>   Countries worldwide have since the beginning of the year embarked on mass vaccination programmes, with mixed results, and are now confronted with the emergence of several variant strains which forces them to move even more quickly.</p><p><blockquote>自今年年初以来，世界各国开始了大规模疫苗接种计划，结果好坏参半，现在面临着几种变异毒株的出现，这迫使它们采取更快的行动。</blockquote></p><p> (Reporting by Matthias Blamont; Editing by Dominique Vidalon)</p><p><blockquote>（马蒂亚斯·布拉蒙特报道；多米尼克·维达隆编辑）</blockquote></p><p>((matthias.blamont@thomsonreuters.com; +33 1 4949 5054 ; @matthiasblamont))</p><p><blockquote>（（matthias.blamont@thomsonreuters.com；+33 1 494 9 505 4；@matthiasblamont））</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sanofi's mRNA COVID-19 vaccine candidate not ready this year-CEO<blockquote>赛诺菲的mRNA COVID-19候选疫苗今年尚未准备好——首席执行官</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSanofi's mRNA COVID-19 vaccine candidate not ready this year-CEO<blockquote>赛诺菲的mRNA COVID-19候选疫苗今年尚未准备好——首席执行官</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2021-02-14 06:47</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><html><body>PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by <a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a>    and U.S. group Translate Bio</p><p><blockquote><html><body>路透巴黎2月13日-由<a href=\"https://laohu8.com/S/GCVRZ\">赛诺菲</a>和美国集团翻译生物</body></html></blockquote></p><p>  \"will not be ready this year,\" the French drugmaker's chief executive told Le Journal du Dimanche newspaper.</p><p><blockquote>“今年不会准备好，”这家法国制药商的首席执行官告诉《星期日报》。</blockquote></p><p>   Clinical trials of this vaccine, which will be based on a technology known as mRNA -- on which lean approved vaccines of Pfizer   /BioNTech    and Moderna    --, are expected to start this quarter.</p><p><blockquote>这种疫苗的临床试验将基于一种名为mRNA的技术——辉瑞/BioNTech和Moderna的精益批准疫苗——预计将于本季度开始。</blockquote></p><p>   In December last year, <a href=\"https://laohu8.com/S/SNYNF\">Sanofi</a> had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data.  </p><p><blockquote>去年12月，<a href=\"https://laohu8.com/S/SNYNF\">赛诺菲</a>该公司表示，在获得积极的临床前数据后，该公司的目标是在2021年下半年“最早可能获得批准”。</blockquote></p><p>   \"This vaccine will not be ready this year, but it could be of use at a later stage all the more if the fight against variants was to continue,\" Paul Hudson was quoted as saying.</p><p><blockquote>报道援引保罗·哈德森的话说：“这种疫苗今年不会准备好，但如果要继续对抗变种，它可能会在稍后阶段发挥更大的作用。”</blockquote></p><p>   The CEO gave no other details. Officials at Sanofi were not available for comment.</p><p><blockquote>首席执行官没有透露其他细节。未能联系到赛诺菲的官员置评。</blockquote></p><p>   The news could mark another blow for Sanofi, already embattled with a delay for another COVID-19 vaccine candidate it hopes to bring to patients and for which the company has teamed up with Britain's GlaxoSmithKline   .</p><p><blockquote>这一消息可能标志着赛诺菲的又一次打击，赛诺菲希望向患者提供的另一种COVID-19候选疫苗的延迟已经陷入困境，该公司已与英国葛兰素史克合作。</blockquote></p><p>   The two groups stunned investors last year by warning their traditional, protein-based COVID-19 jab showed an insufficient immune response in older people, delaying its launch towards the end of 2021.  </p><p><blockquote>去年，这两个组织警告说，他们传统的基于蛋白质的COVID-19疫苗在老年人中显示出免疫反应不足，因此将其推出推迟到2021年底，这让投资者感到震惊。</blockquote></p><p>   To appease critics, Sanofi said last month it had agreed to fill and pack millions of doses of the Pfizer/BioNTech vaccine from July.  </p><p><blockquote>为了安抚批评者，赛诺菲上个月表示，已同意从7月份开始灌装和包装数百万剂辉瑞/BioNTech疫苗。</blockquote></p><p>   Some 108 million people have been reported to be infected by the novel coronavirus globally and more than 2.4 million have died since first cases were identified in China in December 2019, according to a Reuters tally.</p><p><blockquote>据路透社统计，自2019年12月中国发现首例病例以来，全球已有约1.08亿人感染新型冠状病毒病毒，已有超过240万人死亡。</blockquote></p><p>   Countries worldwide have since the beginning of the year embarked on mass vaccination programmes, with mixed results, and are now confronted with the emergence of several variant strains which forces them to move even more quickly.</p><p><blockquote>自今年年初以来，世界各国开始了大规模疫苗接种计划，结果好坏参半，现在面临着几种变异毒株的出现，这迫使它们采取更快的行动。</blockquote></p><p> (Reporting by Matthias Blamont; Editing by Dominique Vidalon)</p><p><blockquote>（马蒂亚斯·布拉蒙特报道；多米尼克·维达隆编辑）</blockquote></p><p>((matthias.blamont@thomsonreuters.com; +33 1 4949 5054 ; @matthiasblamont))</p><p><blockquote>（（matthias.blamont@thomsonreuters.com；+33 1 494 9 505 4；@matthiasblamont））</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞","TBIO":"Telesis Bio, Inc."},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2111807728","content_text":"PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by Sanofi    and U.S. group Translate Bio  \"will not be ready this year,\" the French drugmaker's chief executive told Le Journal du Dimanche newspaper.   Clinical trials of this vaccine, which will be based on a technology known as mRNA -- on which lean approved vaccines of Pfizer   /BioNTech    and Moderna    --, are expected to start this quarter.   In December last year, Sanofi had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data.     \"This vaccine will not be ready this year, but it could be of use at a later stage all the more if the fight against variants was to continue,\" Paul Hudson was quoted as saying.   The CEO gave no other details. Officials at Sanofi were not available for comment.   The news could mark another blow for Sanofi, already embattled with a delay for another COVID-19 vaccine candidate it hopes to bring to patients and for which the company has teamed up with Britain's GlaxoSmithKline   .   The two groups stunned investors last year by warning their traditional, protein-based COVID-19 jab showed an insufficient immune response in older people, delaying its launch towards the end of 2021.     To appease critics, Sanofi said last month it had agreed to fill and pack millions of doses of the Pfizer/BioNTech vaccine from July.     Some 108 million people have been reported to be infected by the novel coronavirus globally and more than 2.4 million have died since first cases were identified in China in December 2019, according to a Reuters tally.   Countries worldwide have since the beginning of the year embarked on mass vaccination programmes, with mixed results, and are now confronted with the emergence of several variant strains which forces them to move even more quickly. (Reporting by Matthias Blamont; Editing by Dominique Vidalon)((matthias.blamont@thomsonreuters.com; +33 1 4949 5054 ; @matthiasblamont))","news_type":1,"symbols_score_info":{"PFE":0.9,"MRNA":0.9,"TBIO":0.9}},"isVote":1,"tweetType":1,"viewCount":453,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":386085542,"gmtCreate":1613112716486,"gmtModify":1631891196969,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"Good👍","listText":"Good👍","text":"Good👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/386085542","repostId":"2110402716","repostType":2,"isVote":1,"tweetType":1,"viewCount":252,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":388631036,"gmtCreate":1613053262725,"gmtModify":1703768850700,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"RIOT is&nbsp;blasting off&nbsp;","listText":"RIOT is&nbsp;blasting off&nbsp;","text":"RIOT is blasting off","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/388631036","repostId":"2110602366","repostType":2,"isVote":1,"tweetType":1,"viewCount":599,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":381691089,"gmtCreate":1612959553041,"gmtModify":1703767475101,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"Hope Elon will think alternative than Bitcoin like Ethereum😄","listText":"Hope Elon will think alternative than Bitcoin like Ethereum😄","text":"Hope Elon will think alternative than Bitcoin like Ethereum😄","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/381691089","repostId":"2110695015","repostType":2,"isVote":1,"tweetType":1,"viewCount":537,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":871365987,"gmtCreate":1637027369289,"gmtModify":1637027369402,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FUBO\">$fuboTV Inc.(FUBO)$</a>守了一年，結果不盡人意。刚全倉賣了，我看不到它明年会有多亮丽的財報。对不起我先止塤⋯⋯","listText":"<a href=\"https://laohu8.com/S/FUBO\">$fuboTV Inc.(FUBO)$</a>守了一年，結果不盡人意。刚全倉賣了，我看不到它明年会有多亮丽的財報。对不起我先止塤⋯⋯","text":"$fuboTV Inc.(FUBO)$守了一年，結果不盡人意。刚全倉賣了，我看不到它明年会有多亮丽的財報。对不起我先止塤⋯⋯","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/871365987","isVote":1,"tweetType":1,"viewCount":3117,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":861891576,"gmtCreate":1632478233295,"gmtModify":1632719866803,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>A useless stock 😡keep on dropping","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>A useless stock 😡keep on dropping","text":"$Tiger Brokers(TIGR)$A useless stock 😡keep on dropping","images":[{"img":"https://static.tigerbbs.com/fd61c83c4ac0b94fe0b5b41f6e84d4e1","width":"1242","height":"2448"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/861891576","isVote":1,"tweetType":1,"viewCount":2237,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":311590845,"gmtCreate":1611808529287,"gmtModify":1703754101859,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OBSV\">$Obseva Sa(OBSV)$</a>Be patient 😅","listText":"<a href=\"https://laohu8.com/S/OBSV\">$Obseva Sa(OBSV)$</a>Be patient 😅","text":"$Obseva Sa(OBSV)$Be patient 😅","images":[{"img":"https://static.tigerbbs.com/71cc7a9e69f3b571eb6ba4d2a14ba4cc","width":"1242","height":"2385"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":1,"link":"https://laohu8.com/post/311590845","isVote":1,"tweetType":1,"viewCount":843,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":885276880,"gmtCreate":1631800609540,"gmtModify":1631883589545,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Everyday goes down&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Everyday goes down&nbsp;","text":"$Tiger Brokers(TIGR)$Everyday goes down","images":[{"img":"https://static.tigerbbs.com/13b660a5446aa4be321d11fa689957a8","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/885276880","isVote":1,"tweetType":1,"viewCount":1871,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":885978034,"gmtCreate":1631753960928,"gmtModify":1631883540728,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SURF\">$Surface Oncology(SURF)$</a>Cut losses and move on.&nbsp;Not worried&nbsp;anymore.","listText":"<a href=\"https://laohu8.com/S/SURF\">$Surface Oncology(SURF)$</a>Cut losses and move on.&nbsp;Not worried&nbsp;anymore.","text":"$Surface Oncology(SURF)$Cut losses and move on. Not worried anymore.","images":[{"img":"https://static.tigerbbs.com/e2d7af4f061899ec6557834e13245ff5","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":1,"link":"https://laohu8.com/post/885978034","isVote":1,"tweetType":1,"viewCount":1557,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":862376143,"gmtCreate":1632840423489,"gmtModify":1632840423489,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Time to cut off and get out of here.&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Time to cut off and get out of here.&nbsp;","text":"$Tiger Brokers(TIGR)$Time to cut off and get out of here.","images":[{"img":"https://static.tigerbbs.com/a9601461a837b047afee5c94f57f1933","width":"1242","height":"2448"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/862376143","isVote":1,"tweetType":1,"viewCount":2625,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":340124773,"gmtCreate":1617360530392,"gmtModify":1631891196887,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/340124773","repostId":"1112964874","repostType":4,"isVote":1,"tweetType":1,"viewCount":435,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":386797164,"gmtCreate":1613271151458,"gmtModify":1631891196919,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"😄","listText":"😄","text":"😄","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/386797164","repostId":"2111722630","repostType":2,"repost":{"id":"2111722630","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1613214929,"share":"https://www.laohu8.com/m/news/2111722630?lang=zh_CN&edition=full","pubTime":"2021-02-13 19:15","market":"us","language":"en","title":"Vivendi plans to distribute 60% of UMG capital to shareholders, list it by year-end<blockquote>维旺迪计划向股东分配60%的UMG capital，年底前上市</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2111722630","media":"Reuters","summary":"By Dominique Vidalon   PARIS, Feb 13 (Reuters) - Vivendi    said on Saturday it planned to distribut","content":"<p><html><body>By Dominique Vidalon</p><p><blockquote><html><body>多米尼克·维达隆</body></html></blockquote></p><p>   PARIS, Feb 13 (Reuters) - Vivendi    said on Saturday it planned to distribute 60% of Universal Music's capital to investors, subject to shareholder approval, and aimed to list its most-prized asset, home to singers such as Lady Gaga and Taylor Swift, by the end of the year. </p><p><blockquote>路透巴黎2月13日-维旺迪周六表示，计划将环球音乐60%的资本分配给投资者，但须经股东批准，并计划将其最有价值的资产（Lady Gaga和泰勒等歌手的所在地）上市。斯威夫特，到今年年底。</blockquote></p><p>   The plan to list Universal represents part of a process launched by Vivendi's top shareholder French billionaire Vincent Bollore to cash in on the music industry's revival.  </p><p><blockquote>环球公司的上市计划是维旺迪最大股东、法国亿万富翁文森特·博洛雷(Vincent Bollore)为从音乐行业的复兴中获利而发起的进程的一部分。</blockquote></p><p>   \"Vivendi’s leading institutional shareholders have been pressing for a number of years for a split or the distribution of Universal Music Group <a href=\"https://laohu8.com/S/UMG.AU\">$(UMG.AU)$</a> to reduce Vivendi’s conglomerate discount,\" Vivendi said in a statement.</p><p><blockquote>“多年来，维旺迪的主要机构股东一直在敦促拆分或分配环球音乐集团<a href=\"https://laohu8.com/S/UMG.AU\">$(UMG.AU)$</a>减少维旺迪的企业集团折扣，”维旺迪在一份声明中表示。</blockquote></p><p>   The French conglomerate said the distribution would take the form of a special dividend.</p><p><blockquote>这家法国企业集团表示，分配将采取特别股息的形式。</blockquote></p><p>    UMG, a holding company currently being incorporated in the Netherlands, will apply for a listing on Euronext in Amsterdam.</p><p><blockquote>目前在荷兰注册成立的控股公司UMG将申请在阿姆斯特丹泛欧交易所上市。</blockquote></p><p>   The transaction has received a favorable response from the  consortium led by China's tech group Tencent   , which now controls 20% of UMG, having bought the stake in two successive waves that valued UMG at 30 billion euros ($36.35 billion), Vivendi said.  </p><p><blockquote>维旺迪表示，该交易得到了中国科技集团腾讯控股牵头的财团的积极回应，该财团目前控制着UMG 20%的股份，连续两波收购了UMG的股份，对UMG的估值为300亿欧元（363.5亿美元）。</blockquote></p><p>   Vivendi said it would hold an extraordinary shareholders meeting on March 29 to modify the company's by-laws and make the distribution possible.</p><p><blockquote>维旺迪表示，将于3月29日召开临时股东大会，修改公司章程，使分配成为可能。</blockquote></p><p>   In addition, Vivendi will propose to distribute a 0.60 euros per share dividend for its 2020 fiscal year at a shareholders meeting scheduled for June 22.    </p><p><blockquote>此外，维旺迪将在定于6月22日召开的股东大会上提议派发2020财年每股0.60欧元的股息。</blockquote></p><p>($1 = 0.8252 euros)</p><p><blockquote>（1美元=0.8252欧元）</blockquote></p><p> (Reporting by Dominique Vidalon. Editing by Jane Merriman)</p><p><blockquote>（多米尼克·维达隆报道。简·梅里曼编辑）</blockquote></p><p>((dominique.vidalon@thomsonreuters.com; +33149495432; Reuters Messaging: dominique.vidalon.reuters.com@reuters.net))</p><p><blockquote>（（dominique.vidalon@thomsonreuters.com；+33149495432；路透社消息：dominique.vidalon.reuters.com@reuters.net））</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vivendi plans to distribute 60% of UMG capital to shareholders, list it by year-end<blockquote>维旺迪计划向股东分配60%的UMG capital，年底前上市</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVivendi plans to distribute 60% of UMG capital to shareholders, list it by year-end<blockquote>维旺迪计划向股东分配60%的UMG capital，年底前上市</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2021-02-13 19:15</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><html><body>By Dominique Vidalon</p><p><blockquote><html><body>多米尼克·维达隆</body></html></blockquote></p><p>   PARIS, Feb 13 (Reuters) - Vivendi    said on Saturday it planned to distribute 60% of Universal Music's capital to investors, subject to shareholder approval, and aimed to list its most-prized asset, home to singers such as Lady Gaga and Taylor Swift, by the end of the year. </p><p><blockquote>路透巴黎2月13日-维旺迪周六表示，计划将环球音乐60%的资本分配给投资者，但须经股东批准，并计划将其最有价值的资产（Lady Gaga和泰勒等歌手的所在地）上市。斯威夫特，到今年年底。</blockquote></p><p>   The plan to list Universal represents part of a process launched by Vivendi's top shareholder French billionaire Vincent Bollore to cash in on the music industry's revival.  </p><p><blockquote>环球公司的上市计划是维旺迪最大股东、法国亿万富翁文森特·博洛雷(Vincent Bollore)为从音乐行业的复兴中获利而发起的进程的一部分。</blockquote></p><p>   \"Vivendi’s leading institutional shareholders have been pressing for a number of years for a split or the distribution of Universal Music Group <a href=\"https://laohu8.com/S/UMG.AU\">$(UMG.AU)$</a> to reduce Vivendi’s conglomerate discount,\" Vivendi said in a statement.</p><p><blockquote>“多年来，维旺迪的主要机构股东一直在敦促拆分或分配环球音乐集团<a href=\"https://laohu8.com/S/UMG.AU\">$(UMG.AU)$</a>减少维旺迪的企业集团折扣，”维旺迪在一份声明中表示。</blockquote></p><p>   The French conglomerate said the distribution would take the form of a special dividend.</p><p><blockquote>这家法国企业集团表示，分配将采取特别股息的形式。</blockquote></p><p>    UMG, a holding company currently being incorporated in the Netherlands, will apply for a listing on Euronext in Amsterdam.</p><p><blockquote>目前在荷兰注册成立的控股公司UMG将申请在阿姆斯特丹泛欧交易所上市。</blockquote></p><p>   The transaction has received a favorable response from the  consortium led by China's tech group Tencent   , which now controls 20% of UMG, having bought the stake in two successive waves that valued UMG at 30 billion euros ($36.35 billion), Vivendi said.  </p><p><blockquote>维旺迪表示，该交易得到了中国科技集团腾讯控股牵头的财团的积极回应，该财团目前控制着UMG 20%的股份，连续两波收购了UMG的股份，对UMG的估值为300亿欧元（363.5亿美元）。</blockquote></p><p>   Vivendi said it would hold an extraordinary shareholders meeting on March 29 to modify the company's by-laws and make the distribution possible.</p><p><blockquote>维旺迪表示，将于3月29日召开临时股东大会，修改公司章程，使分配成为可能。</blockquote></p><p>   In addition, Vivendi will propose to distribute a 0.60 euros per share dividend for its 2020 fiscal year at a shareholders meeting scheduled for June 22.    </p><p><blockquote>此外，维旺迪将在定于6月22日召开的股东大会上提议派发2020财年每股0.60欧元的股息。</blockquote></p><p>($1 = 0.8252 euros)</p><p><blockquote>（1美元=0.8252欧元）</blockquote></p><p> (Reporting by Dominique Vidalon. Editing by Jane Merriman)</p><p><blockquote>（多米尼克·维达隆报道。简·梅里曼编辑）</blockquote></p><p>((dominique.vidalon@thomsonreuters.com; +33149495432; Reuters Messaging: dominique.vidalon.reuters.com@reuters.net))</p><p><blockquote>（（dominique.vidalon@thomsonreuters.com；+33149495432；路透社消息：dominique.vidalon.reuters.com@reuters.net））</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"00700":"腾讯控股","TCEHY":"腾讯控股ADR","QNETCN":"纳斯达克中美互联网老虎指数","TME":"腾讯音乐"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2111722630","content_text":"By Dominique Vidalon   PARIS, Feb 13 (Reuters) - Vivendi    said on Saturday it planned to distribute 60% of Universal Music's capital to investors, subject to shareholder approval, and aimed to list its most-prized asset, home to singers such as Lady Gaga and Taylor Swift, by the end of the year.    The plan to list Universal represents part of a process launched by Vivendi's top shareholder French billionaire Vincent Bollore to cash in on the music industry's revival.     \"Vivendi’s leading institutional shareholders have been pressing for a number of years for a split or the distribution of Universal Music Group $(UMG.AU)$ to reduce Vivendi’s conglomerate discount,\" Vivendi said in a statement.   The French conglomerate said the distribution would take the form of a special dividend.    UMG, a holding company currently being incorporated in the Netherlands, will apply for a listing on Euronext in Amsterdam.   The transaction has received a favorable response from the  consortium led by China's tech group Tencent   , which now controls 20% of UMG, having bought the stake in two successive waves that valued UMG at 30 billion euros ($36.35 billion), Vivendi said.     Vivendi said it would hold an extraordinary shareholders meeting on March 29 to modify the company's by-laws and make the distribution possible.   In addition, Vivendi will propose to distribute a 0.60 euros per share dividend for its 2020 fiscal year at a shareholders meeting scheduled for June 22.    ($1 = 0.8252 euros) (Reporting by Dominique Vidalon. Editing by Jane Merriman)((dominique.vidalon@thomsonreuters.com; +33149495432; Reuters Messaging: dominique.vidalon.reuters.com@reuters.net))","news_type":1,"symbols_score_info":{"00700":0.9,"TME":0.9,"QNETCN":0.6,"TCEHY":0.6}},"isVote":1,"tweetType":1,"viewCount":392,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":384769600,"gmtCreate":1613691100700,"gmtModify":1631888304871,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SURF\">$Surface Oncology(SURF)$</a>😢越走越遠","listText":"<a href=\"https://laohu8.com/S/SURF\">$Surface Oncology(SURF)$</a>😢越走越遠","text":"$Surface Oncology(SURF)$😢越走越遠","images":[{"img":"https://static.tigerbbs.com/f3fe104b2c8b92d95152a7d98cf9aa99","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/384769600","isVote":1,"tweetType":1,"viewCount":1536,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":334228981,"gmtCreate":1610812490343,"gmtModify":1703746975527,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/334228981","repostId":"334951881","repostType":1,"repost":{"id":334951881,"gmtCreate":1610640000000,"gmtModify":1714142114172,"author":{"id":"3570684952272154","authorId":"3570684952272154","name":"英伟达官方","avatar":"https://static.tigerbbs.com/a032ec5702e8405d9f658cdcb484031c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3570684952272154","idStr":"3570684952272154"},"themes":[],"title":"新年新动力：NVIDIA DRIVE赋能领先电动汽车制造商开启2021","htmlText":"蔚来汽车、理想汽车和小鹏汽车均采用NVIDIA开发其智能电动车型。 电动汽车造车新势力已经在行业里站稳脚跟，并通过采用NVIDIA DRIVE保持发展势头。 中国是全球最大的汽车市场，也是电动汽车发展趋势最明显的地方，电动汽车初创企业正在迅速普及。蔚来汽车、理想汽车和小鹏汽车正在推动新能源汽车的初步增长，其全新车型通过扩大电池续航里程并增加AI驱动的功能，突破了日常驾驶的极限。 这三家公司2020年的销量均翻了一倍，总共售出超过十万三千辆汽车。 这些车型拥有更高效的动力系统，并借助 NVIDIA DRIVE 为日常通勤引入全新智能功能。 蔚来推出超算平台 近期，蔚来宣布推出搭载NVIDIA DRIVE Orin的超算平台，驱动其自主和自动驾驶功能。 NIO Adam 超算平台拥有超1000 TOPS算力的性能，以及安全自动驾驶所需的冗余和多样性。它还支持定制化驾驶体验，学习用户驾驶习惯和偏好并持续通过车队数据进行改善。 由NVIDIA DRIVE Orin驱动的超算平台将在旗舰轿车ET7中首次亮相，预计将于2022年开启交付，并将应用在未来每款蔚来车型当中。 由NVIDIA DRIVE Orin 驱动的蔚来旗舰轿车ET7 ET7 拥有超过600英里的续航里程和先进的自动驾驶技术，超越了当前车型的功能。作为首款搭载Adam的汽车，借助33个传感器和高性能计算，ET7可以执行城区、高速以及加电等场景点到点自动驾驶体验。 借助这种集中式、软件定义的计算架构，蔚来未来的电动车型将采用最新AI驱动的功能，将其打造为可永久升级的汽车。 理想汽车驱动向前 去年9月，电动汽车制造商理想汽车表示将采用NVIDIA DRIVE AGX Orin开发其下一代电动汽车。 这些全新车型与一级供应商德赛西威合作开发，具有先进的自动驾驶功能和扩大的电池续航里程以实现真正的智能移动出行。 该高性能平台将赋","listText":"蔚来汽车、理想汽车和小鹏汽车均采用NVIDIA开发其智能电动车型。 电动汽车造车新势力已经在行业里站稳脚跟，并通过采用NVIDIA DRIVE保持发展势头。 中国是全球最大的汽车市场，也是电动汽车发展趋势最明显的地方，电动汽车初创企业正在迅速普及。蔚来汽车、理想汽车和小鹏汽车正在推动新能源汽车的初步增长，其全新车型通过扩大电池续航里程并增加AI驱动的功能，突破了日常驾驶的极限。 这三家公司2020年的销量均翻了一倍，总共售出超过十万三千辆汽车。 这些车型拥有更高效的动力系统，并借助 NVIDIA DRIVE 为日常通勤引入全新智能功能。 蔚来推出超算平台 近期，蔚来宣布推出搭载NVIDIA DRIVE Orin的超算平台，驱动其自主和自动驾驶功能。 NIO Adam 超算平台拥有超1000 TOPS算力的性能，以及安全自动驾驶所需的冗余和多样性。它还支持定制化驾驶体验，学习用户驾驶习惯和偏好并持续通过车队数据进行改善。 由NVIDIA DRIVE Orin驱动的超算平台将在旗舰轿车ET7中首次亮相，预计将于2022年开启交付，并将应用在未来每款蔚来车型当中。 由NVIDIA DRIVE Orin 驱动的蔚来旗舰轿车ET7 ET7 拥有超过600英里的续航里程和先进的自动驾驶技术，超越了当前车型的功能。作为首款搭载Adam的汽车，借助33个传感器和高性能计算，ET7可以执行城区、高速以及加电等场景点到点自动驾驶体验。 借助这种集中式、软件定义的计算架构，蔚来未来的电动车型将采用最新AI驱动的功能，将其打造为可永久升级的汽车。 理想汽车驱动向前 去年9月，电动汽车制造商理想汽车表示将采用NVIDIA DRIVE AGX Orin开发其下一代电动汽车。 这些全新车型与一级供应商德赛西威合作开发，具有先进的自动驾驶功能和扩大的电池续航里程以实现真正的智能移动出行。 该高性能平台将赋","text":"蔚来汽车、理想汽车和小鹏汽车均采用NVIDIA开发其智能电动车型。 电动汽车造车新势力已经在行业里站稳脚跟，并通过采用NVIDIA DRIVE保持发展势头。 中国是全球最大的汽车市场，也是电动汽车发展趋势最明显的地方，电动汽车初创企业正在迅速普及。蔚来汽车、理想汽车和小鹏汽车正在推动新能源汽车的初步增长，其全新车型通过扩大电池续航里程并增加AI驱动的功能，突破了日常驾驶的极限。 这三家公司2020年的销量均翻了一倍，总共售出超过十万三千辆汽车。 这些车型拥有更高效的动力系统，并借助 NVIDIA DRIVE 为日常通勤引入全新智能功能。 蔚来推出超算平台 近期，蔚来宣布推出搭载NVIDIA DRIVE Orin的超算平台，驱动其自主和自动驾驶功能。 NIO Adam 超算平台拥有超1000 TOPS算力的性能，以及安全自动驾驶所需的冗余和多样性。它还支持定制化驾驶体验，学习用户驾驶习惯和偏好并持续通过车队数据进行改善。 由NVIDIA DRIVE Orin驱动的超算平台将在旗舰轿车ET7中首次亮相，预计将于2022年开启交付，并将应用在未来每款蔚来车型当中。 由NVIDIA DRIVE Orin 驱动的蔚来旗舰轿车ET7 ET7 拥有超过600英里的续航里程和先进的自动驾驶技术，超越了当前车型的功能。作为首款搭载Adam的汽车，借助33个传感器和高性能计算，ET7可以执行城区、高速以及加电等场景点到点自动驾驶体验。 借助这种集中式、软件定义的计算架构，蔚来未来的电动车型将采用最新AI驱动的功能，将其打造为可永久升级的汽车。 理想汽车驱动向前 去年9月，电动汽车制造商理想汽车表示将采用NVIDIA DRIVE AGX Orin开发其下一代电动汽车。 这些全新车型与一级供应商德赛西威合作开发，具有先进的自动驾驶功能和扩大的电池续航里程以实现真正的智能移动出行。 该高性能平台将赋","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/334951881","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":479,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3527667803686145","idStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":894786263,"gmtCreate":1628857491852,"gmtModify":1631885579625,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VYNE\">$VYNE Therapeutics Inc.(VYNE)$</a>What happen to this company?&nbsp;","listText":"<a href=\"https://laohu8.com/S/VYNE\">$VYNE Therapeutics Inc.(VYNE)$</a>What happen to this company?&nbsp;","text":"$VYNE Therapeutics Inc.(VYNE)$What happen to this company?","images":[{"img":"https://static.tigerbbs.com/a7c206b6845d177c23ae34177ed6d7a5","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/894786263","isVote":1,"tweetType":1,"viewCount":1728,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":386794771,"gmtCreate":1613271099293,"gmtModify":1631891196956,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"Sanofi failed his 3rd stages...","listText":"Sanofi failed his 3rd stages...","text":"Sanofi failed his 3rd stages...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/386794771","repostId":"2111807728","repostType":2,"repost":{"id":"2111807728","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1613256424,"share":"https://www.laohu8.com/m/news/2111807728?lang=zh_CN&edition=full","pubTime":"2021-02-14 06:47","market":"us","language":"en","title":"Sanofi's mRNA COVID-19 vaccine candidate not ready this year-CEO<blockquote>赛诺菲的mRNA COVID-19候选疫苗今年尚未准备好——首席执行官</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2111807728","media":"Reuters","summary":"PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by Sanofi    and U.S. group Transla","content":"<p><html><body>PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by <a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a>    and U.S. group Translate Bio</p><p><blockquote><html><body>路透巴黎2月13日-由<a href=\"https://laohu8.com/S/GCVRZ\">赛诺菲</a>和美国集团翻译生物</body></html></blockquote></p><p>  \"will not be ready this year,\" the French drugmaker's chief executive told Le Journal du Dimanche newspaper.</p><p><blockquote>“今年不会准备好，”这家法国制药商的首席执行官告诉《星期日报》。</blockquote></p><p>   Clinical trials of this vaccine, which will be based on a technology known as mRNA -- on which lean approved vaccines of Pfizer   /BioNTech    and Moderna    --, are expected to start this quarter.</p><p><blockquote>这种疫苗的临床试验将基于一种名为mRNA的技术——辉瑞/BioNTech和Moderna的精益批准疫苗——预计将于本季度开始。</blockquote></p><p>   In December last year, <a href=\"https://laohu8.com/S/SNYNF\">Sanofi</a> had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data.  </p><p><blockquote>去年12月，<a href=\"https://laohu8.com/S/SNYNF\">赛诺菲</a>该公司表示，在获得积极的临床前数据后，该公司的目标是在2021年下半年“最早可能获得批准”。</blockquote></p><p>   \"This vaccine will not be ready this year, but it could be of use at a later stage all the more if the fight against variants was to continue,\" Paul Hudson was quoted as saying.</p><p><blockquote>报道援引保罗·哈德森的话说：“这种疫苗今年不会准备好，但如果要继续对抗变种，它可能会在稍后阶段发挥更大的作用。”</blockquote></p><p>   The CEO gave no other details. Officials at Sanofi were not available for comment.</p><p><blockquote>首席执行官没有透露其他细节。未能联系到赛诺菲的官员置评。</blockquote></p><p>   The news could mark another blow for Sanofi, already embattled with a delay for another COVID-19 vaccine candidate it hopes to bring to patients and for which the company has teamed up with Britain's GlaxoSmithKline   .</p><p><blockquote>这一消息可能标志着赛诺菲的又一次打击，赛诺菲希望向患者提供的另一种COVID-19候选疫苗的延迟已经陷入困境，该公司已与英国葛兰素史克合作。</blockquote></p><p>   The two groups stunned investors last year by warning their traditional, protein-based COVID-19 jab showed an insufficient immune response in older people, delaying its launch towards the end of 2021.  </p><p><blockquote>去年，这两个组织警告说，他们传统的基于蛋白质的COVID-19疫苗在老年人中显示出免疫反应不足，因此将其推出推迟到2021年底，这让投资者感到震惊。</blockquote></p><p>   To appease critics, Sanofi said last month it had agreed to fill and pack millions of doses of the Pfizer/BioNTech vaccine from July.  </p><p><blockquote>为了安抚批评者，赛诺菲上个月表示，已同意从7月份开始灌装和包装数百万剂辉瑞/BioNTech疫苗。</blockquote></p><p>   Some 108 million people have been reported to be infected by the novel coronavirus globally and more than 2.4 million have died since first cases were identified in China in December 2019, according to a Reuters tally.</p><p><blockquote>据路透社统计，自2019年12月中国发现首例病例以来，全球已有约1.08亿人感染新型冠状病毒病毒，已有超过240万人死亡。</blockquote></p><p>   Countries worldwide have since the beginning of the year embarked on mass vaccination programmes, with mixed results, and are now confronted with the emergence of several variant strains which forces them to move even more quickly.</p><p><blockquote>自今年年初以来，世界各国开始了大规模疫苗接种计划，结果好坏参半，现在面临着几种变异毒株的出现，这迫使它们采取更快的行动。</blockquote></p><p> (Reporting by Matthias Blamont; Editing by Dominique Vidalon)</p><p><blockquote>（马蒂亚斯·布拉蒙特报道；多米尼克·维达隆编辑）</blockquote></p><p>((matthias.blamont@thomsonreuters.com; +33 1 4949 5054 ; @matthiasblamont))</p><p><blockquote>（（matthias.blamont@thomsonreuters.com；+33 1 494 9 505 4；@matthiasblamont））</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sanofi's mRNA COVID-19 vaccine candidate not ready this year-CEO<blockquote>赛诺菲的mRNA COVID-19候选疫苗今年尚未准备好——首席执行官</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSanofi's mRNA COVID-19 vaccine candidate not ready this year-CEO<blockquote>赛诺菲的mRNA COVID-19候选疫苗今年尚未准备好——首席执行官</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2021-02-14 06:47</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><html><body>PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by <a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a>    and U.S. group Translate Bio</p><p><blockquote><html><body>路透巴黎2月13日-由<a href=\"https://laohu8.com/S/GCVRZ\">赛诺菲</a>和美国集团翻译生物</body></html></blockquote></p><p>  \"will not be ready this year,\" the French drugmaker's chief executive told Le Journal du Dimanche newspaper.</p><p><blockquote>“今年不会准备好，”这家法国制药商的首席执行官告诉《星期日报》。</blockquote></p><p>   Clinical trials of this vaccine, which will be based on a technology known as mRNA -- on which lean approved vaccines of Pfizer   /BioNTech    and Moderna    --, are expected to start this quarter.</p><p><blockquote>这种疫苗的临床试验将基于一种名为mRNA的技术——辉瑞/BioNTech和Moderna的精益批准疫苗——预计将于本季度开始。</blockquote></p><p>   In December last year, <a href=\"https://laohu8.com/S/SNYNF\">Sanofi</a> had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data.  </p><p><blockquote>去年12月，<a href=\"https://laohu8.com/S/SNYNF\">赛诺菲</a>该公司表示，在获得积极的临床前数据后，该公司的目标是在2021年下半年“最早可能获得批准”。</blockquote></p><p>   \"This vaccine will not be ready this year, but it could be of use at a later stage all the more if the fight against variants was to continue,\" Paul Hudson was quoted as saying.</p><p><blockquote>报道援引保罗·哈德森的话说：“这种疫苗今年不会准备好，但如果要继续对抗变种，它可能会在稍后阶段发挥更大的作用。”</blockquote></p><p>   The CEO gave no other details. Officials at Sanofi were not available for comment.</p><p><blockquote>首席执行官没有透露其他细节。未能联系到赛诺菲的官员置评。</blockquote></p><p>   The news could mark another blow for Sanofi, already embattled with a delay for another COVID-19 vaccine candidate it hopes to bring to patients and for which the company has teamed up with Britain's GlaxoSmithKline   .</p><p><blockquote>这一消息可能标志着赛诺菲的又一次打击，赛诺菲希望向患者提供的另一种COVID-19候选疫苗的延迟已经陷入困境，该公司已与英国葛兰素史克合作。</blockquote></p><p>   The two groups stunned investors last year by warning their traditional, protein-based COVID-19 jab showed an insufficient immune response in older people, delaying its launch towards the end of 2021.  </p><p><blockquote>去年，这两个组织警告说，他们传统的基于蛋白质的COVID-19疫苗在老年人中显示出免疫反应不足，因此将其推出推迟到2021年底，这让投资者感到震惊。</blockquote></p><p>   To appease critics, Sanofi said last month it had agreed to fill and pack millions of doses of the Pfizer/BioNTech vaccine from July.  </p><p><blockquote>为了安抚批评者，赛诺菲上个月表示，已同意从7月份开始灌装和包装数百万剂辉瑞/BioNTech疫苗。</blockquote></p><p>   Some 108 million people have been reported to be infected by the novel coronavirus globally and more than 2.4 million have died since first cases were identified in China in December 2019, according to a Reuters tally.</p><p><blockquote>据路透社统计，自2019年12月中国发现首例病例以来，全球已有约1.08亿人感染新型冠状病毒病毒，已有超过240万人死亡。</blockquote></p><p>   Countries worldwide have since the beginning of the year embarked on mass vaccination programmes, with mixed results, and are now confronted with the emergence of several variant strains which forces them to move even more quickly.</p><p><blockquote>自今年年初以来，世界各国开始了大规模疫苗接种计划，结果好坏参半，现在面临着几种变异毒株的出现，这迫使它们采取更快的行动。</blockquote></p><p> (Reporting by Matthias Blamont; Editing by Dominique Vidalon)</p><p><blockquote>（马蒂亚斯·布拉蒙特报道；多米尼克·维达隆编辑）</blockquote></p><p>((matthias.blamont@thomsonreuters.com; +33 1 4949 5054 ; @matthiasblamont))</p><p><blockquote>（（matthias.blamont@thomsonreuters.com；+33 1 494 9 505 4；@matthiasblamont））</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞","TBIO":"Telesis Bio, Inc."},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2111807728","content_text":"PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by Sanofi    and U.S. group Translate Bio  \"will not be ready this year,\" the French drugmaker's chief executive told Le Journal du Dimanche newspaper.   Clinical trials of this vaccine, which will be based on a technology known as mRNA -- on which lean approved vaccines of Pfizer   /BioNTech    and Moderna    --, are expected to start this quarter.   In December last year, Sanofi had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data.     \"This vaccine will not be ready this year, but it could be of use at a later stage all the more if the fight against variants was to continue,\" Paul Hudson was quoted as saying.   The CEO gave no other details. Officials at Sanofi were not available for comment.   The news could mark another blow for Sanofi, already embattled with a delay for another COVID-19 vaccine candidate it hopes to bring to patients and for which the company has teamed up with Britain's GlaxoSmithKline   .   The two groups stunned investors last year by warning their traditional, protein-based COVID-19 jab showed an insufficient immune response in older people, delaying its launch towards the end of 2021.     To appease critics, Sanofi said last month it had agreed to fill and pack millions of doses of the Pfizer/BioNTech vaccine from July.     Some 108 million people have been reported to be infected by the novel coronavirus globally and more than 2.4 million have died since first cases were identified in China in December 2019, according to a Reuters tally.   Countries worldwide have since the beginning of the year embarked on mass vaccination programmes, with mixed results, and are now confronted with the emergence of several variant strains which forces them to move even more quickly. (Reporting by Matthias Blamont; Editing by Dominique Vidalon)((matthias.blamont@thomsonreuters.com; +33 1 4949 5054 ; @matthiasblamont))","news_type":1,"symbols_score_info":{"PFE":0.9,"MRNA":0.9,"TBIO":0.9}},"isVote":1,"tweetType":1,"viewCount":453,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":380505507,"gmtCreate":1612545961809,"gmtModify":1703763573398,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"Not&nbsp;too&nbsp;good","listText":"Not&nbsp;too&nbsp;good","text":"Not too good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/380505507","repostId":"2109722637","repostType":4,"isVote":1,"tweetType":1,"viewCount":307,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":314833916,"gmtCreate":1612328809735,"gmtModify":1703760420713,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"Not a good news for humankind&nbsp;","listText":"Not a good news for humankind&nbsp;","text":"Not a good news for humankind","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/314833916","repostId":"2108734055","repostType":4,"isVote":1,"tweetType":1,"viewCount":479,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":854144431,"gmtCreate":1635430190262,"gmtModify":1635430194316,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MSFT\">$Microsoft(MSFT)$</a>yes","listText":"<a href=\"https://laohu8.com/S/MSFT\">$Microsoft(MSFT)$</a>yes","text":"$Microsoft(MSFT)$yes","images":[{"img":"https://static.tigerbbs.com/0eb41ea3c0195e48a0dfe8acf0183127","width":"1242","height":"2448"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/854144431","isVote":1,"tweetType":1,"viewCount":2415,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":885979248,"gmtCreate":1631753804784,"gmtModify":1631885579481,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VYNE\">$VYNE Therapeutics Inc.(VYNE)$</a>Finally I decid dto&nbsp;give up&nbsp;VYNE.&nbsp;","listText":"<a href=\"https://laohu8.com/S/VYNE\">$VYNE Therapeutics Inc.(VYNE)$</a>Finally I decid dto&nbsp;give up&nbsp;VYNE.&nbsp;","text":"$VYNE Therapeutics Inc.(VYNE)$Finally I decid dto give up VYNE.","images":[{"img":"https://static.tigerbbs.com/8fc215c384330dfbc19b446070356be5","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/885979248","isVote":1,"tweetType":1,"viewCount":1192,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":116703862,"gmtCreate":1622817549156,"gmtModify":1631885579842,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VYNE\">$VYNE Therapeutics Inc.(VYNE)$</a>What happen to this company?","listText":"<a href=\"https://laohu8.com/S/VYNE\">$VYNE Therapeutics Inc.(VYNE)$</a>What happen to this company?","text":"$VYNE Therapeutics Inc.(VYNE)$What happen to this company?","images":[{"img":"https://static.tigerbbs.com/c5ef85bbab8d041dabda3826393ab5da","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/116703862","isVote":1,"tweetType":1,"viewCount":1169,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":104498878,"gmtCreate":1620401462094,"gmtModify":1631885579931,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VYNE\">$VYNE Therapeutics Inc.(VYNE)$</a>When will this stock can go up again?","listText":"<a href=\"https://laohu8.com/S/VYNE\">$VYNE Therapeutics Inc.(VYNE)$</a>When will this stock can go up again?","text":"$VYNE Therapeutics Inc.(VYNE)$When will this stock can go up again?","images":[{"img":"https://static.tigerbbs.com/9f45ebe32278206b1409cf4db45055ad","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/104498878","isVote":1,"tweetType":1,"viewCount":1249,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":347867166,"gmtCreate":1618486266755,"gmtModify":1631891196872,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/347867166","repostId":"345255525","repostType":1,"repost":{"id":345255525,"gmtCreate":1618321130667,"gmtModify":1631885011003,"author":{"id":"3574041672989370","authorId":"3574041672989370","name":"克罗伊","avatar":"https://static.tigerbbs.com/43f42ce5b407f9b6b1fffd313280897b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574041672989370","idStr":"3574041672989370"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SENS\">$Senseonics(SENS)$</a>Sell or hold?","listText":"<a href=\"https://laohu8.com/S/SENS\">$Senseonics(SENS)$</a>Sell or hold?","text":"$Senseonics(SENS)$Sell or hold?","images":[{"img":"https://static.tigerbbs.com/9cc56fda0d2e9cc3f457a88bab42af3a","width":"1170","height":"2026"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/345255525","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":890,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":360081157,"gmtCreate":1613795587279,"gmtModify":1631891196894,"author":{"id":"3553468686052330","authorId":"3553468686052330","name":"ChunPeng","avatar":"https://static.tigerbbs.com/f64d90920e0ea1b28e2b3c3a97f2a493","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553468686052330","idStr":"3553468686052330"},"themes":[],"htmlText":"Sign of market recover","listText":"Sign of market recover","text":"Sign of market recover","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/360081157","repostId":"2112844585","repostType":2,"isVote":1,"tweetType":1,"viewCount":449,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}